Complicated Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Complicated Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-06-25FDA Approved: ZEMDRI (PLAZOMICIN) — Original Application (Cipla Therapeutics Inc.)
FDA approved ZemdrI (plazomicin) under an original NDA from Cipla Therapeutics Inc. as a new antibiotic for complicated urinary tract infect…
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections [Phase 2]
Pfizer reports Phase 2 results from a comparative trial of NXL104 combined with ceftazidime versus a comparator in adults with complicated u…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection [Phase 1]
This update reports the completion of a Phase 1 pharmacokinetic study evaluating RO7079901 in combination with meropenem in participants wit…
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae
Completed clinical trial investigating cases of serious infections due to carbapenem-resistant Enterobacteriaceae across multiple infection …
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs) [Phase 2]
Phase 2 trial evaluating safety, pharmacokinetics, and efficacy of ceftazidime-avibactam compared with cefepime in children aged 3 months to…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP [Phase 3]
Phase 3 trial comparing Meropenem-Vaborbactam to Piperacillin-Tazobactam in adults with complicated urinary tract infection and acute pyelon…
-
CLINICAL_TRIALS trial_result · 2017-09-08Clinical Trial Update: GSK2251052 in Complicated Urinary Tract Infection [Phase 2]
Phase 2 trial of GSK2251052 for complicated urinary tract infection was terminated; results posted in 2017.
-
FDA approval · 2017-08-29FDA Approved: VABOMERE — Original Application (Melinta Therapeutics, LLC)
FDA approved VABOMERE (meropenem-vaborbactam) from Melinta Therapeutics as an original application.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048) [Phase 3]
Phase 3 study evaluating ertapenem sodium for complicated urinary tract infections has completed, assessing safety, tolerability, and effica…
-
CLINICAL_TRIALS research · 2017-01-18Clinical Trial Update: Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)
Clinical trial RESCUING studied management and outcomes of hospitalised patients with complicated urinary tract infections; the study status…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) [Phase 3]
Phase 3 trial comparing ceftazidime-avibactam to doripenem followed by oral therapy for adults with complicated urinary tract infections, in…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) [Phase 3]
Phase 3 trial comparing ceftazidime-avibactam to doripenem followed by oral therapy for hospitalized adults with complicated UTIs, including…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens [Phase 3]
Phase 3 trial update for ceftazidime-avibactam in complicated urinary tract infection and complicated intra-abdominal infection has been com…
-
FDA label_change · 2015-09-02FDA Approved: AVYCAZ — Supplemental Application (Allergan, Inc.)
FDA supplemental application for Avycaz (ceftazidime/avibactam) submitted by Allergan to modify the product labeling.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of Time [Phase 4]
A Phase 4 trial evaluating a higher-dose, shorter-duration levofloxacin regimen for complicated urinary tract infection was terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care [NA]
A completed clinical trial update focused on optimizing diagnosis and antibiotic prescribing for acutely ill children in primary care.
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis [Phase 3]
A Phase 3 trial comparing CXA-201 versus levofloxacin in complicated urinary tract infection with pyelonephritis has completed and posted re…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections [Phase 2]
Phase 2 trial update on safety and efficacy of IV CXA-101 plus IV ceftazidime for complicated urinary tract infections.
-
FDA approval · 2014-12-19FDA Approved: ZERBAXA — Original Application (Merck Sharp & Dohme LLC)
FDA approved ZERBAXA (ceftolozane and tazobactam) via Original Application for the treatment of complicated intra-abdominal infections and c…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections [Phase 3]
A Phase 3 safety and tolerability trial in hospitalized children compared doripenem with cefepime for complicated urinary tract infections a…
-
CLINICAL_TRIALS research · 2014-04-03Clinical Trial Update: An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.
This document discusses an observational study evaluating the use of ertapenem for outpatient parenteral antibiotic therapy in patients with…
-
CLINICAL_TRIALS trial_result · 2014-02-03Clinical Trial Update: Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections [Phase 2]
A completed Phase 2 trial evaluating a coadministered ceftaroline fosamil and NXL104 regimen versus doripenem in adults with complicated uri…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
A completed clinical trial evaluating the safety and effectiveness of doripenem in Filipino patients with nosocomial pneumonia, complicated …
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis [Phase 3]
Phase 3 evaluation of Doripenem for complicated lower urinary tract infection and pyelonephritis has been completed.
-
CLINICAL_TRIALS trial_result · 2010-03-01Clinical Trial Update: Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055) [Phase 3]
Phase 3 clinical trial assessing the safety and tolerability of ertapenem sodium for the treatment of complicated urinary tract infections; …